Systematic Review of Cost-Effectiveness Analyses Comparing Open and Minimally Invasive Lumbar Spinal Surgery

被引:5
|
作者
Eseonu, Kelechi [1 ,3 ]
Oduoza, Uche [1 ]
Monem, Mohamed [2 ]
Tahir, Mohamed [1 ]
机构
[1] Royal Natl Orthopaed Hosp Stanmore, London, England
[2] St Marys Hosp, London, England
[3] Royal Natl Orthopaed Hosp Stanmore, Brockley Hill, Stanmore HA7 4LP, Middx, England
来源
关键词
minimally invasive; minimal access surgery; lumbar spine; discectomy; cost; cost-utility; cost-effectiveness; cost-minimization; systematic review; QUALY; QALY; quality-adjusted life year; INTERBODY FUSION; DEGENERATIVE SPONDYLOLISTHESIS; SURGICAL-TREATMENT; UTILITY ANALYSIS; OUTCOMES; HEALTH; CARE; LAMINECTOMY; POSTERIOR; STENOSIS;
D O I
10.14444/8297
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Minimally invasive surgery (MIS) has benefits over open surgery for lumbar decompression and/or fusion. Published literature on its cost-effectiveness vs open techniques is mixed.Objective: Systematically review the cost-effectiveness of minimally invasive vs open lumbar spinal surgical decompression, fusion, or discectomy using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.Methods: A systematic electronic search of databases (MEDLINE, Embase, and Cochrane Library) and a manual search from the cost-effectiveness analysis (CEA) database and National Health Service economic evaluation database was conducted. Studies that included adult populations undergoing surgery for degenerative changes in the lumbar spine (stenosis, radiculopathy, and spondylolisthesis) and reported outcomes of costing analysis, CEA, or incremental cost-effectiveness ratio were included.Results: A total of 17 studies were included. Three studies assessed outcomes of MIS vs open discectomy. All 3 reported statistically significant lower total costs in the MIS, compared with the open group, with similar reported gains in quality-adjusted life years (QALYs). Two studies reported cost differences in MIS vs open laminectomy, with significantly lower total costs attributed to the MIS group. Twelve studies reported findings on the relative direct costs of MIS vs open lumbar fusion. Among those, 3 of the 4 studies comparing single -level MIS-transforaminal lumbar interbody fusion (TLIF) and open TLIF reported lower total costs associated with MIS procedures. Six studies reported cost evaluation of single-and 2 -level TLIF procedures. Lower total costs were found in the MIS group compared with the open fusion group in all studies except for the subgroup analysis of 2 -level fusions in a single study. Three of these 6 studies reported cost-effectiveness (cost/QALY). MIS fusion was found to be more cost-effective than open fusion in all 3 studies.Conclusion: The studies reviewed were of poor to moderate methodological quality. Generally, studies reported a reduced cost associated with MIS vs open surgery and suggested better cost-effectiveness, particularly in MIS vs open single-and 2 -level TLIF procedure. Most studies had a high risk of bias. Therefore, this review was unable to conclusively recommend MIS over open surgery from a cost-effectiveness perspective.
引用
收藏
页码:612 / 624
页数:14
相关论文
共 50 条
  • [21] Safety, efficacy, and cost-effectiveness of minimally invasive esophagectomies versus open esophagectomies: an umbrella review
    Ramjit, Sinead E.
    Ashley, Emmaline
    Donlon, Noel E.
    Weiss, Andreas
    Doyle, Frank
    Heskin, Leonie
    DISEASES OF THE ESOPHAGUS, 2022, 35 (12)
  • [22] Minimally invasive surgery for lumbar spinal stenosis
    Wouter A. Moojen
    Niels A. Van der Gaag
    European Journal of Orthopaedic Surgery & Traumatology, 2016, 26 (7) : 681 - 684
  • [23] Spinal Biologics in Minimally Invasive Lumbar Surgery
    Chang, Kevin Y.
    Hsu, Wellington K.
    MINIMALLY INVASIVE SURGERY, 2018, 2018
  • [24] Minimally invasive surgery for lumbar spinal stenosis
    Moojen, Wouter A.
    Peul, Wilco C.
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [25] Minimally invasive lumbar decompression for lumbar stenosis: review of clinical outcomes and cost effectiveness
    Johans, S. J.
    Amin, B. Y.
    Mummaneni, P. V.
    JOURNAL OF NEUROSURGICAL SCIENCES, 2015, 59 (01) : 37 - 45
  • [26] Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis
    Zhang, Wei
    Islam, Nazrul
    Ma, Canice
    Anis, Aslam H.
    PHARMACOECONOMICS, 2015, 33 (04) : 327 - 340
  • [27] A systematic review of cost-effectiveness analyses of pharmacogenomic interventions
    Phillips, KA
    Van Bebber, SL
    PHARMACOGENOMICS, 2004, 5 (08) : 1139 - 1149
  • [28] Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
    Wan, Y.
    Zeng, F.
    Tan, H.
    Lu, Y.
    Zhang, Y.
    Zhao, L.
    You, R.
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (05) : 979 - 1015
  • [29] Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
    Y. Wan
    F. Zeng
    H. Tan
    Y. Lu
    Y. Zhang
    L. Zhao
    R. You
    Osteoporosis International, 2022, 33 : 979 - 1015
  • [30] Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis
    Wei Zhang
    Nazrul Islam
    Canice Ma
    Aslam H. Anis
    PharmacoEconomics, 2015, 33 : 327 - 340